'Designer baby' rules up for debate (UK)
By BBC News,
BBC News
| 07. 17. 2004
The Human Fertilisation and Embryology Authority (HFEA) is to debate its policy on creating babies who can help sick siblings.
It will consider a doctor's request to select an embryo for a Northern Ireland couple that is a blood match with their son, who has a rare blood disorder.
Currently embryos can only be screened for serious genetic disorders.
Dr Mohamed Taranissi, the director of London's Assisted Reproduction Gynaecology Centre, is pursuing a rule change in a bid to help two-year-old Joshua Fletcher, from Moira, County Down.
Joshua has a potentially fatal blood disorder called Diamond Blackfan anaemia (DBA), which can be treated by using stem cells to stimulate his body to produce healthy red blood cells.
| |
We only want to give our son the best chance for a cure for a condition which could take his life
Joe Fletcher
Father of baby Joshua |
Neither his parents, Joe and Julie, nor his five-year-old brother Adam are close enough matches to give him the stem cells he needs.
But IVF technology...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...
